<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brief Bioinform</journal-id>
<journal-id journal-id-type="iso-abbrev">Brief. Bioinformatics</journal-id>
<journal-id journal-id-type="publisher-id">bib</journal-id>
<journal-title-group>
<journal-title>Briefings in Bioinformatics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1467-5463</issn>
<issn pub-type="epub">1477-4054</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29304189</article-id>
<article-id pub-id-type="pmc">6954408</article-id>
<article-id pub-id-type="doi">10.1093/bib/bbx170</article-id>
<article-id pub-id-type="publisher-id">bbx170</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metabolomics technology and bioinformatics for precision medicine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Azad</surname>
<given-names>Rajeev K</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shulaev</surname>
<given-names>Vladimir</given-names>
</name>
<xref ref-type="corresp" rid="bbx170-cor1"></xref>
<!--<email>shulaev@unt.edu</email>-->
</contrib>
</contrib-group>
<author-notes>
<corresp id="bbx170-cor1">Corresponding author: Vladimir Shulaev, Department of Biological Sciences, BioDiscovery Institute, University of North Texas, Denton, TX 76210, USA. Tel.: 940-369-5368; Fax: 940-565-3821; E-mail: <email>shulaev@unt.edu</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2018-01-03" pub-type="epub">
<day>03</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>1</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>20</volume>
<issue>6</issue>
<fpage>1957</fpage>
<lpage>1971</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="bbx170.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Precision medicine is rapidly emerging as a strategy to tailor medical treatment to a small group or even individual patients based on their genetics, environment and lifestyle. Precision medicine relies heavily on developments in systems biology and omics disciplines, including metabolomics. Combination of metabolomics with sophisticated bioinformatics analysis and mathematical modeling has an extreme power to provide a metabolic snapshot of the patient over the course of disease and treatment or classifying patients into subpopulations and subgroups requiring individual medical treatment. Although a powerful approach, metabolomics have certain limitations in technology and bioinformatics. We will review various aspects of metabolomics technology and bioinformatics, from data generation, bioinformatics analysis, data fusion and mathematical modeling to data management, in the context of precision medicine.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>precision medicine</kwd>
<kwd>metabolomics</kwd>
<kwd>metabolite profiling</kwd>
<kwd>NMR</kwd>
<kwd>mass spectrometry</kwd>
<kwd>GC-MS; LC-MS</kwd>
<kwd>bioinformatics</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Allergy and Infectious Diseases</named-content>
<named-content content-type="funder-identifier">10.13039/100000060</named-content>
</funding-source>
<award-id>5R01AI111962-02</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Diabetes and Digestive and Kidney Diseases</named-content>
<named-content content-type="funder-identifier">10.13039/100000062</named-content>
</funding-source>
<award-id>DK109524-01</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="15"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>